DT&CRO Co. Ltd. (383930) fair value: what the stock is really worth
As of Nov 20, 2026: fair value (intrinsic value) of DT&CRO Co. Ltd. stock ₩1,831, price ₩1,890, that is 3.1% below the price, quality 33 out of 100. Rating: fairly valued. The value is an estimate: none of our valuation models currently applies, it draws on revenue and assets compared with similar companies. Updated daily.
- Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free
DT&CRO Co. Ltd.
383930 · KQThe stock is already about fairly priced, weak company and falling price: meets none of the 3 rules.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 16, 2026.
How to read this chart
48‑month range ₩1,450 – ₩24,400 · fair‑value band ₩1,373 – ₩2,288 · the ₩1,890 price screens above the ₩1,831 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 16, 2026.
Every Wednesday you see whether DT&CRO Co. is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Company profile
DT&CRO CO., Ltd. operates as a full-service CRO provider in South Korea.
Show moreShow less
The company conducts a series of consigned studies ranging from non-clinical GLP toxicity, PK, and efficacy tests required for licensing of pharmaceuticals, chemicals, health functional food, cosmetics, and medical devices to analysis, bioactivity, clinical trials, and licensing consulting.
DT&CRO CO., Ltd. was founded in 2017 and is based in Yongin-si, South Korea.
Stock analysis
DT&CRO Co. Ltd. (383930) currently trades at ₩1,890, while our estimate is ₩1,831, so the stock looks roughly fairly valued today (gap 3.2%).
Show more
Valuation
None of our valuation models currently applies to this company, usually because of losses or heavy investment. The estimate draws on revenue and assets compared with similar companies and is less precise than a model-based fair value.
Scenario range: ₩1,373 (bear) to ₩2,288 (bull), the price of ₩1,890 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 33/100 (below-average quality), in the Healthcare sector.
Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.
DT&CRO Co. Ltd. reported revenue of 47.7B KRW in FY2025 versus 32.7B KRW in FY2021, a compound +9.9%/yr. Reported net income was −2.8B KRW in FY2025.
Key figures
Market cap 24.2B KRW (≈ $18.1M) Micro · P/S ratio 0.51 · EPS (TTM) ₩-1,337 · Net margin −34.9% · Return on equity −105% · Return on assets (EBIT) −3.8% (5-year average) · Operating margin −58.1% · Revenue (TTM) 49.0B KRW.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 6 out of 100 (low confidence).
What moves the price
The share trades about 50% below its 52-week high and 30% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −4% fair-value upside, at −3%, 383930 screens cheaper than that median.
Fair Value
Quality Score breakdown
It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.
Revenue & earnings trend
Watch 383930, get fair value alerts →
Compare DT&CRO Co. Ltd. with another stock
Price, fair value, quality and upside side by side.
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Biotechnology · 854 stocks
Valuation Multiplesvs Biotechnology median · lower = cheaper
Strength profile in five axes (Snowflake)
Context: sector, industry, market
- Is the Health Care sector expensive or cheap?
- P/E, EV/EBITDA and margins by industry (reference tables)
- EBIT margin by industry
- P/S ratio by industry
- PEG screener for stocks with fair value
- Undervalued stocks: South Korean Stocks
- Valuation of the Korea market
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Biotechnology stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value | Compare |
|---|---|---|---|---|
| Regeneron Pharmaceuticals, Inc REGN | $920.69 | $1,275.02 | +38% | vs 383930 |
| Vertex Pharmaceuticals Incorporated VRTX | $515.02 | $566.52 | +10% | vs 383930 |
| Samsung Biologics Co 207940 | ₩1,355,000 | ₩1,490,500 | +10% | vs 383930 |
| argenx SE ARGX | $925.70 | $908.40 | −2% | vs 383930 |
| CSL Limited CSL | A$197.29 | A$188.80 | −4% | vs 383930 |
| BeOne Medicines AG 6160 | HK$230.80 | HK$152.92 | −34% | vs 383930 |
| Moderna, Inc MRNA | $195.00 | $119.97 | −38% | vs 383930 |
| Revolution Medicines, Inc RVMD | $161.20 | $83.14 | −48% | vs 383930 |
| Celltrion, Inc 068270 | ₩213,000 | ₩74,574 | −65% | vs 383930 |
| Royalty Pharma plc RPRX | $68.45 | $19.01 | −72% | vs 383930 |
Explore undervalued stocks
More undervalued Healthcare stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is DT&CRO Co. Ltd. (383930) overvalued or undervalued?
What is the fair value of 383930?
What is the quality score of 383930?
What is the price target for DT&CRO Co. Ltd. (383930)?
What is the DT&CRO Co. Ltd. stock forecast for 2026?
What is the revenue of DT&CRO Co. Ltd. (383930)?
What is the intrinsic value of DT&CRO Co. Ltd. (383930)?
Is DT&CRO Co. Ltd. stock overvalued or undervalued in 2026?
Is fair value the same as the market price of 383930?
How much is DT&CRO Co. Ltd. worth?
What do the bullish and bearish scenarios say about 383930?
How solid is the balance sheet of DT&CRO Co. Ltd. (383930)?
How far is 383930 from its 52-week high?
Which stocks are comparable to DT&CRO Co. Ltd.?
Is DT&CRO Co. Ltd. stock attractive at the current price?
Is it still worth investing in stocks now?
What is the share price of DT&CRO Co. Ltd. (383930)?
What should I pay attention to with DT&CRO Co. Ltd. right now?
Key figures of DT&CRO Co. Ltd.
How large is the market capitalisation of DT&CRO Co. Ltd. (383930)?
What is the P/S ratio of DT&CRO Co. Ltd. (383930)?
What are the earnings per share of DT&CRO Co. Ltd. (383930)?
What is the net margin of DT&CRO Co. Ltd. (383930)?
What is the return on equity of DT&CRO Co. Ltd. (383930)?
What is the EBIT return on assets of DT&CRO Co. Ltd. (383930)?
What is the operating margin of DT&CRO Co. Ltd. (383930)?
How fast is revenue growing at DT&CRO Co. Ltd. (383930)?
How fast are earnings growing at DT&CRO Co. Ltd. (383930)?
How much free cash flow does DT&CRO Co. Ltd. (383930) generate?
How much net debt does DT&CRO Co. Ltd. (383930) carry?
Watch DT&CRO Co. Ltd. in the live analysis
One click puts DT&CRO Co. Ltd. on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 28,000+ stock screener.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.